Literature DB >> 17218092

Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.

Fabrice Ciesielski1, Natacha Rochel, Dino Moras.   

Abstract

The crystal structure of the ligand binding domain (LBD) of the wild-type Vitamin D receptor (VDR) of zebrafish bound to Gemini, a synthetic agonist ligand with two identical side chains branching at carbon 20 reveals a ligand-dependent structural rearrangement of the ligand binding pocket (LBP). The rotation of a Leu side chain opens the access to a channel that can accommodate the second side chain of the ligand. The 25% increase of the LBP's volume does not alter the essential agonist features of VDR. The possibility to adapt the LBP to novel ligands with different chemistry and/or structure opens new perspectives in the design of more specifically targeted ligands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218092     DOI: 10.1016/j.jsbmb.2006.12.003

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  23 in total

Review 1.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

2.  Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.

Authors:  Tiphaine Huet; Hubert Maehr; Hong Jin Lee; Milan R Uskokovic; Nanjoo Suh; Dino Moras; Natacha Rochel
Journal:  Medchemcomm       Date:  2011       Impact factor: 3.597

3.  Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR.

Authors:  Matthew D Krasowski; Ai Ni; Lee R Hagey; Sean Ekins
Journal:  Mol Cell Endocrinol       Date:  2010-07-06       Impact factor: 4.102

Review 4.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength.

Authors:  Tae-Kang Kim; Jin Wang; Zorica Janjetovic; Jianjun Chen; Robert C Tuckey; Minh N Nguyen; Edith K Y Tang; Duane Miller; Wei Li; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-04-21       Impact factor: 4.102

6.  Quantification of the vitamin D receptor-coregulator interaction.

Authors:  Arnaud Teichert; Leggy A Arnold; Steve Otieno; Yuko Oda; Indre Augustinaite; Tim R Geistlinger; Richard W Kriwacki; R Kiplin Guy; Daniel D Bikle
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

7.  Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.

Authors:  Anna Y Belorusova; Nanjoo Suh; Hong Jin Lee; Jae Young So; Hubert Maehr; Natacha Rochel
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-17       Impact factor: 4.292

8.  Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.

Authors:  Hong Jin Lee; Shiby Paul; Nadi Atalla; Paul E Thomas; Xinjie Lin; Ill Yang; Brian Buckley; Gang Lu; Xi Zheng; You-Rong Lou; Allan H Conney; Hubert Maehr; Luciano Adorini; Milan Uskokovic; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

9.  Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio.

Authors:  Theodore A Craig; Stacy Sommer; Caroline R Sussman; Joseph P Grande; Rajiv Kumar
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

10.  Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation.

Authors:  Hubert Maehr; Hong Jin Lee; Bradford Perry; Nanjoo Suh; Milan R Uskokovic
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.